×
Close
註冊
登入
主页
用户
博客
照片
视频
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
用户指南
问答
谁看过我
反馈
语言
English
中文
推广
所有
MeSH descriptor
Mesh Subheading
Mesh Supplementary Concept
Mesh Pharmacological Action
search
搜索
清除所有
MeSH 搜索器
AND
OR
加入MeSH搜索引擎
搜索PubMed论文列
清除所有
Eukaryotic Initiation Factor-4G
A component of eukaryotic initiation factor-4F that is involved in multiple protein interactions at the site of translation initiation. Thus it may serve a role in bringing together various initiation factors at the site of translation initiation.
推出的年份: 2003
副标题
administration and dosage
adverse effects
agonists
analysis
antagonists and inhibitors
biosynthesis
blood
cerebrospinal fluid
chemical synthesis
chemistry
classification
deficiency
drug effects
economics
genetics
history
immunology
isolation and purification
metabolism
pharmacokinetics
pharmacology
physiology
poisoning
radiation effects
standards
supply and distribution
therapeutic use
toxicity
ultrastructure
urine
树号:
D12.776.835.725.868.500.875
MeSH 单一 ID:
D039603
进入的组:
Eukaryotic Initiation Factor 4G
EIF4G
Peptide Initiation Factor EIF-4G
Peptide Initiation Factor EIF 4G
Eukaryotic Translation Initiation Factor 4 gamma
Eukaryotic-Translation Initiation Factor 4G
Eukaryotic Translation Initiation Factor 4G
EIF-4G
EIF 4G
Eukaryotic Peptide Initiation Factor-4G
Eukaryotic Peptide Initiation Factor 4G
早前的内容:
Peptide Initiation Factors (1997-2002)
All MeSH Categories
Chemicals and Drugs Category
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Ribosomal Proteins [D12.776.835]
Peptide Initiation Factors [D12.776.835.725]
Eukaryotic Initiation Factors [D12.776.835.725.868]
Eukaryotic Initiation Factor-4F [D12.776.835.725.868.500]
Eukaryotic Initiation Factor-4A [D12.776.835.725.868.500.500]
Eukaryotic Initiation Factor-4E [D12.776.835.725.868.500.750]
Eukaryotic Initiation Factor-4G [D12.776.835.725.868.500.875]
thumb_up
Like
share
分享
favorite
书签
0
0
0
0
0
0
0
留言 (
0
)
gif
登入或註冊以發表你的留言
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin
留言 (0)